Highly effective biosynthesis of N-acetylated human thymosin β4 (Tβ4) in Escherichia coli

Reference

• Hannappel E. Thymosin beta4 and its posttranslational modifications. Ann N Y Acad Sci. 2010;1194:27–35.
   PubMed Web of Science ®Google Scholar
• Hu SK, Low TL, Goldstein AL. Modulation of terminal deoxynucleotidyl transferase activity by thymosin. Mol Cell Biochem. 1981;41:49–58.
   PubMed Web of Science ®Google Scholar
• Safer D, Golla R, Nachmias VT. Isolation of a 5-kilodalton actin-sequestering peptide from human blood platelets. Proc Natl Acad Sci USA. 1990;87:2536–2540.
   PubMed Web of Science ®Google Scholar
• Badamchian M, Fagarasan MO, Danner RL. Thymosin beta(4) reduces lethality and down-regulates inflammatory mediators in endotoxin-induced septic shock. Int Immunopharmacol. 2003;3:1225–1233.
   PubMed Web of Science ®Google Scholar
• Cavasin MA. Therapeutic potential of thymosin-beta4 and its derivative N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) in cardiac healing after infarction. Am J Cardiovasc Drugs. 2006;6:305–311.
   PubMedGoogle Scholar
• Sosne G, Szliter EA, Barrett R, et al. Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury. Exp Eye Res. 2002;74:293–299.
   PubMed Web of Science ®Google Scholar
• Sosne G, Qiu P, Christopherson PL, et al. Thymosin beta 4 suppression of corneal NFkappaB: a potential anti-inflammatory pathway. Exp Eye Res. 2007;84:663–669.
   PubMed Web of Science ®Google Scholar
• Sosne G, Christopherson PL, Barrett RP, et al. Thymosin-beta4 modulates corneal matrix metalloproteinase levels and polymorphonuclear cell infiltration after alkali injury. Invest Ophthalmol Vis Sci. 2005;46:2388–2395.
   PubMed Web of Science ®Google Scholar
• Young JD, Lawrence AJ, Mac Lean AG, et al. Thymosin beta 4 sulfoxide is an anti-inflammatory agent generated by monocytes in the presence of glucocorticoids. Nat Med. 1999;5:1424–1427.
   PubMed Web of Science ®Google Scholar
• Huang LC, Jean D, Proske RJ, et al. Ocular surface expression and in vitro activity of antimicrobial peptides. Curr Eye Res. 2007;32:595–609.
   PubMed Web of Science ®Google Scholar
• Bock-Marquette I, Saxena A, White MD, et al. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature. 2004;432:466–472.
   PubMed Web of Science ®Google Scholar
• Ho JH, Tseng KC, Ma WH, et al. Thymosin beta-4 upregulates anti-oxidative enzymes and protects human cornea epithelial cells against oxidative damage. Br J Ophthalmol. 2008;92:992–997.
   PubMed Web of Science ®Google Scholar
• Ho JH, Chuang CH, Ho CY, et al. Internalization is essential for the antiapoptotic effects of exogenous thymosin beta-4 on human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2007;48:27–33.
   PubMed Web of Science ®Google Scholar
• Ehrlich HP, Sprague WH. Thymosin beta4 enhances repair by organizing connective tissue and preventing the appearance of myofibroblasts. Ann N Y Acad Sci. 2010;1194:118–124.
   PubMed Web of Science ®Google Scholar
• Smart N, Risebro CA, Melville AAD, et al. Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization. Nature. 2007;445:177–182.
   PubMed Web of Science ®Google Scholar
• Malinda KM, Goldstein AL, Kleinman HK. Thymosin beta 4 stimulates directional migration of human umbilical vein endothelial cells. FASEB J. 1997;11:474–481.
   PubMed Web of Science ®Google Scholar
• Grant DS, Kinsella JL, Kibbey MC, et al. Matrigel induces thymosin beta4 gene in differentiating endothelial cells. J Cell Sci. 1995;108:3685–3694.
   PubMed Web of Science ®Google Scholar
• Sosne G, Siddiqi A, Kurpakus-Wheater M. Thymosin-beta4 inhibits corneal epithelial cell apoptosis after ethanol exposure in vitro. Invest Ophthalmol Vis Sci. 2004;45:1095–1100.
   PubMed Web of Science ®Google Scholar
• Qiu P, Kurpakus-Wheater M, Sosne G. Matrix metalloproteinase activity is necessary for thymosin beta 4 promotion of epithelial cell migration. J Cell Physiol. 2007;212:165–173.
   PubMed Web of Science ®Google Scholar
• Roy P, Rajfur Z, Jones D, et al. Local photorelease of caged thymosin beta4 in locomoting keratocytes causes cell turning. J Cell Biol. 2001;153:1035–1048.
   PubMed Web of Science ®Google Scholar
• Sosne G, Hafeez S, Greenberry AL II, et al. Thymosin beta4 promotes human conjunctival epithelial cell migration. Curr Eye Res. 2002;24:268–273.
   PubMed Web of Science ®Google Scholar
• Sosne G, Xu L, Prach L, et al. Thymosin beta 4 stimulates laminin-5 production independent of TGF-beta. Exp Cell Res. 2004;293:175–183.
   PubMed Web of Science ®Google Scholar
• Sosne G, Qiu P, Goldstein AL, et al. Biological activities of thymosin beta4 defined by active sites in short peptide sequences. FASEB J. 2010;24:2144–2151.
   PubMed Web of Science ®Google Scholar
• Crockford D, Turjman N, Allan C, et al. Thymosin beta4: structure, function, and biological properties supporting current and future clinical applications. Ann N Y Acad Sci. 2010;1194:179–189.
   PubMed Web of Science ®Google Scholar
• Ruff D, Crockford D, Girardi G, et al. A randomized, placebo-controlled, single and multiple dose study of intravenous thymosin beta4 in healthy volunteers. Ann N Y Acad Sci. 2010;1194:223–229.
   PubMed Web of Science ®Google Scholar
• Smart N, Bollini S, Dube KN, et al. De novo cardiomyocytes from within the activated adult heart after injury. Nature. 2011;474:640–644.
   PubMed Web of Science ®Google Scholar
• Xiong Y, Mahmood A, Meng Y, et al. Treatment of traumatic brain injury with thymosin β4 in rats. J Neurosurg. 2011;114:102–115.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang ZG, Morris D, et al. Neurological functional recovery after thymosin beta4 treatment in mice with experimental auto encephalomyelitis. Neuroscience. 2009;164:1887–1893.
   PubMed Web of Science ®Google Scholar
• Kozaczuk A, Selmi A, Bednarek R. Bacterial expression, purification and angiogenesis-promoting activity of human thymosin β4. Protein Expr Purif. 2013;90:142–152.
   PubMed Web of Science ®Google Scholar
• Li T, Ma SY, Tang XC, et al. Production and characterization of highly purified recombinant thymosin beta 4 in Escherichia coli. Protein Expr Purif. 2013;90:90–95.
   PubMed Web of Science ®Google Scholar
• Tsuji Y, Kitahara-Tanabe N, Noguchi K, et al. Production in Escherichia coli of human thymosin beta 4 as chimeric protein with human tumor necrosis factor. Biochem Int. 1989;18:501–508.
   PubMedGoogle Scholar
• Mackay DT, Botting CH, Taylor GL, et al. An acetylase with relaxed specificity catalyses protein N-terminal acetylation in Sulfolobus solfataricus. Mol Microbiol. 2007;64:1540–1548.
   PubMed Web of Science ®Google Scholar
• Ren Y, Yao X, Dai H, et al. Production of Nα-acetylated thymosin α1 in Escherichia coli. Microb Cell Fact. 2011;10:26.
   PubMed Web of Science ®Google Scholar
• Urbancikova M, Hitchcock-DeGregori SE. Requirement of amino-terminal modification for striated muscle alpha-tropomyosin function. J Biol Chem. 1994;269:24310–24315.
   PubMed Web of Science ®Google Scholar
• Rudman D, Hollins BM, Kutner MB, et al. Three type of α-melanocyte-stimulating hormone: bioactivity and half-lives. Am J Physiol. 1983;245:E47–E54.
   PubMedGoogle Scholar